We’re committed to providing an affordable treatment option, accessible to all couples that are trying to get pregnant, for use in the privacy and comfort of home.

Stork OTC Woman Doctor

The Stork OTC is an FDA-cleared home conception device for over-the-counter-use by couples who are trying to conceive. The product improves upon the established cervical cap technique providing couples with an easy-to-use option in the privacy and comfort of their home.

The Stork OTC is intended to assist the patient population that has been diagnosed with common difficulties such as: diminished sperm count, sperm motility, unfavorable vaginal environment, and unexplained fertility. Patients today are seeking out less-invasive, more affordable options to complement their path to becoming pregnant; many using diagnostic tools to enhance their chances for conception. Priced at $59.99 per device, The Stork OTC can provide these patients with a first step option designed to complement their fertility treatment path before trying more invasive procedures.

Stork OTC Intravaginal


  • Pregnancy success rate of up to 20%1.
  • Prevention of backflow of semen into the vagina5.
  • Prolonged exposure of the spermatozoa (Sperm cell) to the cervical mucus5.
  • Enables sperm to bypass the vaginal environment quickly, reducing the risk of sperm loss in the vaginal tract5.
  • Considered a less invasive method of aiding in conception with a limited number of risks6.

The device utilizes cervical cap insemination, a technique used as an effective, in-clinic treatment option for decades. Historical cervical cap insemination success rate have been well-documented. The Stork OTC enables couples to use this technique at-home maintaining the privacy and intimacy many feel they lose when trying becomes “trying”.

The Stork OTC combines a condom-like integrated collection with a tampon-like anatomical delivery system that is atraumatic to semen and the vaginal environment. From collection to placement, the process is completed by engaging only three buttons. The product collects, delivers, and places the sperm close to the opening of the cervix.

The Stork OTC can be used as a complement to natural intercourse before couples are referred out for additional treatment options. The Stork is recommended for use during the ovulatory phase of the menstrual cycle. Patients are encouraged to use the device with an ovulation test kit to determine their most fertile days.

The Conceptacle®

The Conceptacle consists of a silicone condom-like sheath with an HSSA tested silicone cervical cap resting within the reservoir. The Conceptacle is used to collect the semen during intercourse but can alternatively be used with donor sperm. The cervical cap is removed from the sheath and placed into the applicator for ease of placing at the opening of the cervix.

The Applicator

The Applicator cradles and compresses the cervical cap for ease of tracking through the vagina to the opening of the cervix. There are three activation buttons on the applicator that the patient will engage with to use the product. The cervical cap is cradled and compressed with the Plunger Tab (Button 1). Once the device is placed into the vaginal tract by the user, the semen is pushed from the reservoir tip towards the mouth of the cap with the Plunger Release Button (Button 2). The cap is released from the device using the Cap Release Button (Button 3).

Button 1 - Plunger Tab (seals the cervical cap)

Button 2 - Plunger Release (opens the cervical cap)

Button 3 - Cap Release (releases the cervical cap, attaching a tampon-like pull chord)


  • 1 single-use device = $59.99+s/h

Cost-Comparison Table

*(All figures based on national averages. IUI average cost includes fertility medications)

Treatment Options*Average Success RatesAverage Price***
Cervical Cap Insemination10-20%1,2,$59.99**
Intrauterine Insemination (IUI)10-20%3$700-$2000+
In Vitro Fertilization20-35%4$12,400+

Insurance Involvement

Today, approximately 15 out of the 50 states offer partial reimbursement for fertility treatments for those struggling to conceive naturally. Many of the states that do offer limited or partial reimbursement have lengthy waiting times and rigorous processes of approval before patients are reimbursed. The Stork OTC is uniquely priced so patients do not have the additional stress of submitting to the reimbursement process of their insurance company.

The Stork OTC is intended as an aid in conception and does not guarantee pregnancy.

Rinovum recommends all patients consult their healthcare provider if they have any questions concerning The Stork OTC as an aid in conception. If you are a healthcare provider and have any questions regarding use of the product, the prescription device (The Stork), or any other questions related to our OTC product, please contact Rinovum, we would be happy to hear from you at:

The Stork Ib2C, Inc. 
A Rinovum Women’s Health Company
300 Oxford Drive, Suite 330
Monroeville, PA 15146


  1. Corsono SL, Batzar FR, Otis C, Fee D. The cervical cap for home artificial insemination. J. Reprod. Med., 1986, May; 31 (5): 349-52.
  2. Subak et al. Therapeutic donor insemination: a prospective randomized trial of fresh versus frozen sperm. American Journal of obstetrics and Gynocology, 1992, June; 166 (6pt1):1597-604.
  3. ASRM. 2012 Intrauterine Insemination Fact Sheet [Accessed 2016] http://www.reproductivefacts.org/globalassets/rf/news-and-publications/bookletsfact-sheets/english-fact-sheets-and-info-booklets/intrauterine_insemination_iui_factsheet.pdf
  4.  RESOLVE.ORG. 2016 What Are My Chances with IVF? [Accessed April 2016]. http://www.resolve.org/family-building-options/ivf-art/what-are-my-chances-of-success-with-ivf.html
  5.  “A Prospective, randomized, cross-over comparison of two methods of artificial insemination by donor on the incidence of conception: Intracervical insemination by straw versus cervical cap”, Human Reproduction, Vol. 12, no.9 1945-1948, 1997, Flierman, Hendrikus, et al.
  6. “Evaluation of the effect of a cervical cap device on sperm functional characteristics in vitro”, ANDROLOGIA 33, (2001), M. C. Mahony.
  7. “Artificial insemination with fresh donor semen using the cervical cap technique: a review of 278 cases”, Obstet Gynecol. 1982 Aug;60(2):195-9, Bergquist CA, Rock JA, Miller J, Guzick DS, Wentz AC, Jones GS.
  8. “Randomized controlled trial of cervical cap with intracervical reservoir versus standard intracervical injection to inseminate cryopreserved donor sperm”, Human Reproduction, Vol. 11, no.1, pp.84-87, 1996, C. Coulson, E.A. McLaughlin, S. Harris, W.C.L. Ford and M.G.R. Hull.